Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells

Te-Chih Cheng,Zhong-Hao Din,Jui-Hsin Su,Yu-Jen Wu,Chih-I Liu
DOI: https://doi.org/10.3390/md15080238
2017-08-02
Marine Drugs
Abstract:Sinulariolide is a natural product extracted from the cultured-type soft coral <i>Sinularia flexibilis</i>, and possesses bioactivity against the movement of several types of cancer cells. However, the molecular pathway behind its effects on human bladder cancer remain poorly understood. Using a human bladder cancer cell line as an in vitro model, this study investigated the underlying mechanism of sinulariolide against cell migration/invasion in TSGH-8301 cells. We found that sinulariolide inhibited TSGH-8301 cell migration/invasion, and the effect was concentration-dependent. Furthermore, the protein expressions of matrix metalloproteinases (MMPs) MMP-2 and MMP-9, as well as urokinase, were significantly decreased after 24-h sinulariolide treatment. Meanwhile, the increased expression of tissue inhibitors of metalloproteinases (TIMPs) TIMP-1 and TIMP-2 were in parallel with an increased concentration of sinulariolide. Finally, the expressions of several key phosphorylated proteins in the mTOR signaling pathway were also downregulated by sinulariolide treatment. Our results demonstrated that sinulariolide has significant effects against TSGH-8301 cell migration/invasion, and its effects were associated with decreased levels of MMP-2/-9 and urokinase expression, as well as increased TIMP-1/TIMP-2 expression. The inhibitory effects were mediated by reducing phosphorylation proteins of the PI3K, AKT, and mTOR signaling pathway. The findings suggested that sinulariolide is a good candidate for advanced investigation with the aim of developing a new drug for the treatment of human bladder cancer.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
This paper aims to explore the inhibitory effect of Sinulariolide on the migration and invasion of human bladder cancer cells and its molecular mechanism. Specifically, the researchers used the human bladder cancer cell line TSGH - 8301 as an in - vitro model and experimentally verified that Sinulariolide can inhibit the migration and invasion abilities of these cells in a concentration - dependent manner. In addition, the study also found that Sinulariolide can significantly reduce the protein expression levels of matrix metalloproteinase - 2 (MMP - 2), matrix metalloproteinase - 9 (MMP - 9) and urokinase, and increase the expression levels of tissue inhibitor of metalloproteinase - 1 (TIMP - 1) and tissue inhibitor of metalloproteinase - 2 (TIMP - 2). Finally, the study showed that Sinulariolide can also down - regulate the expression of several key phosphorylated proteins in the mTOR signaling pathway. These results indicate that Sinulariolide exerts its inhibitory effect on the migration and invasion of bladder cancer cells by reducing phosphorylated proteins in the PI3K, AKT and mTOR signaling pathways, which may provide a potential candidate substance for the development of new drugs for the treatment of bladder cancer.